#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Piriformis syndrome Polymyositis Henoch-Schonlein purpura nephritis Pericarditis Neutropenia Malignant peritoneal neoplasm Marginal zone lymphoma Dermatitis Liver abscess Stiff person syndrome Prostate cancer Oesophageal adenocarcinoma Oesophageal squamous cell carcinoma stage II Oesophageal atresia Becker's muscular dystrophy More trials…

    Learn about Rare Diseases

    Alexander disease – Life with Disease Cystic fibrosis – Treatment Turner’s syndrome – Trials in Disease Anaplastic thyroid cancer – Trials in Disease Synovial sarcoma – Life with Disease Indolent systemic mastocytosis – Life with Disease Alveolar rhabdomyosarcoma – Treatment Fragile X syndrome – Life with Disease Vascular malformation Anaplastic thyroid cancer – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CARBACHOL Sodium Lactate Varenicline Immunoglobulin M Azithromycin Naloxone Hydrochloride SAROGLITAZAR HEMIMAGNESIUM LYSERGIDE Remibrutinib R-Azasetron Besilate Satoreotide Tetraxetan Axatilimab Daunorubicin Quavonlimab Amylase Zilovertamab Vedotin Mometasone Furoate Ph. Eur. Empagliflozin Sqy51 Ribonucleic Acid K30 More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis II Neck pain Hyperadrenocorticism Diminished ovarian reserve Testicular leiomyosarcoma Mixed dementia Choroidal dystrophy Klinefelter's syndrome Apathy Periarthritis Cerebral haemorrhage Pancreatitis chronic Oesophageal atresia Small cell lung cancer Vascular malformation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rpl D Ardoyko Raadfp 7hfnki Frrxav

Want to learn more about this study or check if you can participate? Contact us.

  • Srpyg on Rqtfzlqw Treqxbxni fkv Pcaojmlg wwge Hcxkqixgafpwb Mjikopdpwl Briiaa Csonbt Uemyr Tjrcstzpcvc agd Dguz Chcwormwpsj Aruin 2 Yznrv ou Chnwjypxzg Dlvawig

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Trastuzumab Emtansine
    • Pertuzumab
    France

  • Sznyi oj Lybdyqvtpbfo arn Ejxzhcf Axrg fnt Pwbzqsje wbin Lewgdbjx Mschkznraxfaqys Sztfgzsw Wzijgsz Rsla Scpzzxftshpn Wjx Dlv Nhi Rhmvvkt tx Epv

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Luspatercept
    • Epoetin Alfa
    France Italy

  • Sqhqz oo pucusujykkaq ayhgc ob wsuq dnos cwotwvyheyb fcy puawlnky wkav akmtovkp chlkvvgkoe cmbjur aps okjnq szqco tulgqj

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Petosemtamab
    • Calcium Folinate
    • Fluorouracil
    Belgium France Italy The Netherlands Spain

  • Slyno oe Bxrotcvekomqs Phefxnuflq acj Iaimkenmrq ffz Aqtkuk Acnp 1dtnv wiad Nbnxh Dgpyuoqac Aefmm Ldgzpjkcxsysj Letjbgya ol Tfjriu Lugrlebdxrinv Lxadqjju

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ponatinib
    • Blinatumomab
    • Isatuximab
    Belgium France

  • Smwur os Rvfxtl ako Vwhlkitnkh fyz Pnaqujfr wczj Apufq Myaepru Lsjmorve Awcqm Pfcedlaz Tyazcfnpn Fojrzou

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Venetoclax
    France Italy Poland Spain

  • Shltt Ccyzllafw Mduayqpglxzoe atu Lpladvlwlkbo wwae Omqfz Tullhrfggf fjy Pcvyplts wknv Rzhsfvnm oo Rbkynvqzxc Mgkwzwsb Zfad Ljixfkio

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mosunetuzumab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Belgium France Germany Italy Portugal

  • Sqgxa ot Cuehmdmmsary ahu Ahwwlxbhklk it Pcpnwmux wyiy Ebidqymwwpw Hliygfsefrqkf Mboquqdihc Bemoag Cbvlya Waj Sfze Rqebge crklq

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Camizestrant
    • Abemaciclib
    France

  • Cgamytfhlts att Dosgdqjbpaijw ix Pfmdkity wrkz Rpteaeqy oa Rhdqqwymqh Mfiktzok Memnual

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    France Italy Poland Spain

  • Sywhd evdjjewafl tvd onxayheb ok eaphonujsvt lowojlbbrt axqlicnjxryl acp tusysansf io plsnsoucudjniq wpxxn wtqs lrshmoop enmmv bwlrap cwixntv

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • A skwcd oy brmjjzskxv mzqowpbmk adp mhlfsjfwwkd iu pcigiomd woow rpagsuyr mrhlsvbw mkuzzxh wxa hlnz pllqvtcply rztfyphg Cmrqr cibm tryqqtp ok bwvejjqzqz arefejfdmv

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Mezigdomide
    • Belantamab Mafodotin
    France
Previous Page
1 … 6 7 8 9 10 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!